Cancer Pain Market Demand, Share & Growth by 2034

Coverage: By Drug Type (Opioids, Non-Opioids, Nerve blockers); Disease Indication (Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00007742
  • Category : Life Sciences
  • No. of Pages : 151
  • Available Report Formats : pdf-format excel-format
  • Last update date : January 27, 2025
Cancer Pain Market Demand, Share & Growth by 2034
Report Date: January 27, 2025   |   Report Code: TIPRE00007742 Email: sales@theinsightpartners.com

2025 Market Size

US$ 5.06 Bn

Base year value

2034 Forecast

US$ 9.03 Bn

Projected by 2034

CAGR 2026-2034

6.65 %

Growth rate

Addressable Market

US$ 63.71 Bn

(2026-2034)

Cancer Pain market is expected to register a CAGR of 6.65% from 2026 to 2034, with the market size expanding from US$ 5.06 Billion in 2025 to US$ 9.03 Billion by 2034.

The growth in cancer pain is attributed to the increasing prevalence of cancer, aging populations, and improvements in the cancer treatment approach. This report gives an in-depth perspective on the dynamics of the market, its size, segmentation, and competitive landscape. The drivers of the market include the increased demand for efficient pain management solutions and the introduction of new therapies.

Purpose of the Report

The report Cancer Pain Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Cancer Pain Market Segmentation

Drug Type

  • Opioids
  • Non-Opioids
  • Nerve blockers

Disease Indication

  • Lung Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Blood Cancer

Market Assessment and Insights

  • Global market for Cancer Pain was valued at US$ 5.06 Billion in 2025
  • Annual market size is expected to reach US$ 9.03 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 63.71 Billion
  • Market is anticipated to register a CAGR of 6.65% during the forecast period
  • The United States represents a key market, supported by Growing Prevalence of Cancer, Demand for Effective Pain Management, Advancements in Pain Management Therapies, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Develop Effective Therapies, Development in drug delivery systems, Development of Non-Opioid Analgesics are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Aoxing Pharmaceutical Company, Inc., BioDelivery Sciences International, Inc., Daiichi Sankyo Co., Ltd., Grunenthal Pharma GmbH & Co. KG,, Hisamitsu Pharmaceutical Co., Inc., Insys Therapeutics, Inc., Mundipharma International Limited, Orexo AB, Pfizer Inc., Teva Pharmaceutical Industries Limited, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Cancer Pain Market: Strategic Insights

cancer-pain-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Cancer Pain Market Growth Drivers

  • Growing Prevalence of Cancer: The cancer pain market is rapidly increasing globally due to several driving factors. Most probably, the most contributing factor is the growing prevalence of the disease, primarily resulting from the aging population of almost every country.
  • Demand for Effective Pain Management: The more patients affected by cancer, the greater the resultant need for effective solutions in pain management. In terms of the growing awareness of the benefits of improved cancer treatments and diagnosis, there is an enhanced need for pain management during and after treatment. Because growth in the market is driven by increased awareness about the importance of pain management and a wider therapeutic range, there is an increase in demand for a better quality of life. Added to this, growing interest in the quality of life for patients with cancer and rising medical costs worldwide create favorable conditions for increasing the market for cancer pain.
  • Advancements in Pain Management Therapies: Innovations in drug formulations, including extended-release opioids, non-opioid analgesics, and transdermal patches, are driving the adoption of cancer pain treatments.
  • Growing Awareness About Cancer Pain Management: Awareness campaigns by healthcare organizations and governments have improved recognition of the importance of managing cancer-related pain.

Cancer Pain Market Future Trends

  • Patient-centric Treatments: Tailored treatment plans by the clinical requirements of individual patients represent one of personalized medicine. This would develop precisely targeted and effective pain management techniques. Besides, advancements in drug delivery systems, such as implantable pumps, and focused drug delivery will also provide significant improvements in pain control with fewer side effects.
  • Coverage of Digital Health: The final emerging trend is the convergence of digital health technologies wearables and telemedicine that will help monitor patient symptomatology and response to treatment, thereby enabling management from a distance.
  • Multimodal Pain Therapy: The growing trend to multimodal pain therapy at every stage would ensure even more optimal relief. According to the research studies, the novelty that is going to emerge in the future would be drugs related to new therapeutic and innovative concepts to deal with the confusing aspect of cancer pain.

Cancer Pain Market Opportunities

  • Develop Effective Therapies: The incidence of cancers and patient numbers are growing alarmingly, in need of more effective therapies for pain management. This creates an immense market demand. These innovative therapeutic agents, targeted therapies and immunotherapies truly hold great promise for the unmet needs of cancer pain management.
  • Development in drug delivery systems: Drug delivery innovations such as oral formulations, topical formulations, and injectable formulations, would enhance compliance in treating patients. The growing interest in patient-centered care and quality-of-life-related concerns opens up exciting avenues for the development of multifaceted programs in pain management, integrating pharmacological and non-pharmacological interventions. Having extensive availability, digital health technologies will enable monitoring of patients in a remote manner, provide patient-specific treatment plans, and access care in the most underserved regions. Thus, proper resolution of the tough issues of cancer pain will create monumental opportunities for health service providers, pharmaceutical firms, and manufacturers of medical appliances.
  • Development of Non-Opioid Analgesics: Increased focus on non-opioid pain relief solutions, such as cannabinoids, nerve block therapies, and targeted biologics, presents opportunities to address concerns over opioid addiction and side effects.

Cancer Pain Market Report Scope

Report Attribute Details
Market size in 2025 US$ 5.06 Billion
Market Size by 2034 US$ 9.03 Billion
Global CAGR (2026 - 2034) 6.65%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Drug Type
  • Opioids
  • Non-Opioids
  • Nerve blockers
By Disease Indication
  • Lung Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Blood Cancer
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Aoxing Pharmaceutical Company, Inc.
  • BioDelivery Sciences International, Inc.
  • Daiichi Sankyo Co., Ltd.
  • Grunenthal Pharma GmbH & Co. KG,
  • Hisamitsu Pharmaceutical Co., Inc.
  • Insys Therapeutics, Inc.
  • Mundipharma International Limited
  • Orexo AB
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Limited

Cancer Pain Market Players Density: Understanding Its Impact on Business Dynamics

The Cancer Pain Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

cancer-pain-market-cagr

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Cancer Pain Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Cancer Pain Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The leading players of the market are: Aoxing Pharmaceutical Company, Inc., BioDelivery Sciences International, Inc., Daiichi Sankyo Co., Ltd., Grunenthal Pharma GmbH & Co. KG,, Hisamitsu Pharmaceutical Co., Inc., Insys Therapeutics, Inc., Mundipharma International Limited, Orexo AB Pfizer Inc., Teva Pharmaceutical Industries Limited

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

Some of the customization options available based on request are additional 3 to 5 company profiles and country-specific analysis of 3 to 5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Personalized medicine is gaining importance with the trend of tailoring treatment according to individual patient needs. Innovative drug delivery systems are expected to improve pain control while reducing side effects. Digital health technologies are integrating to monitor patient symptoms, track treatment response, and facilitate remote pain management. Multimodal pain management, including pharmacological and non-pharmacological interventions, is becoming increasingly prevalent. With advancing research, novel therapeutic agents and innovative approaches are expected to continue the quest toward addressing the complex challenge of cancer pain.

Cancer Pain Market is expected to grow at a CAGR of 6.65% from 2026 to 2034

Principal drivers of the cancer pain market are, thus, several. Among them are the facts of rising cancer prevalence among age populations. The improved techniques of cancer treatment and diagnosis increase the rates of survival but have also increased the need for effective pain management. In addition, greater awareness of pain control as well as an escalation in overall healthcare spending around the world drive growth in the market. Other trends and developments that are creating new opportunities in the cancer pain market include novel therapeutic agents, innovative drug delivery systems, and the involvement of digital health technologies.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA